BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 10480207)

  • 1. Visual field constriction is not limited to children treated with vigabatrin.
    Wohlrab G; Boltshauser E; Schmitt B; Schriever S; Landau K
    Neuropediatrics; 1999 Jun; 30(3):130-2. PubMed ID: 10480207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visual field constriction in epilepsy patients treated with vigabatrin and other antiepileptic drugs: a prospective study.
    Schmitz B; Schmidt T; Jokiel B; Pfeiffer S; Tiel-Wilck K; Rüther K
    J Neurol; 2002 Apr; 249(4):469-75. PubMed ID: 11967655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visual fields at school-age in children treated with vigabatrin in infancy.
    Gaily E; Jonsson H; Lappi M
    Epilepsia; 2009 Feb; 50(2):206-16. PubMed ID: 19215279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Visual field disturbances in epileptic patients treated with vigabatrin (sevril)].
    Gross-Tsur V; Lahat E; Banin E; Shahar E; Shalev R
    Harefuah; 2002 Mar; 141(3):247-9, 315. PubMed ID: 11944216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visual field loss in young children and mentally handicapped adolescents receiving vigabatrin.
    Werth R; Schädler G
    Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):3028-35. PubMed ID: 16799049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study of visual field and vigabatrin treatment in children].
    Pelosse B; Momtchilova M; Roubergue A; Doummar D; Billette de Villemeur T; Laroche L
    J Fr Ophtalmol; 2001 Dec; 24(10):1075-80. PubMed ID: 11913238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is visual field constriction in epilepsy patients treated with vigabatrin reversible?
    Schmidt T; Rüther K; Jokiel B; Pfeiffer S; Tiel-Wilck K; Schmitz B
    J Neurol; 2002 Aug; 249(8):1066-71. PubMed ID: 12195456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vigabatrin in the treatment of childhood epilepsy: a retrospective chart review of efficacy and safety profile.
    Camposano SE; Major P; Halpern E; Thiele EA
    Epilepsia; 2008 Jul; 49(7):1186-91. PubMed ID: 18479386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visual fields in young children treated with vigabatrin.
    Agrawal S; Mayer DL; Hansen RM; Fulton AB
    Optom Vis Sci; 2009 Jun; 86(6):767-73. PubMed ID: 19417698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visual impairment in children with epilepsy treated with vigabatrin.
    Gross-Tsur V; Banin E; Shahar E; Shalev RS; Lahat E
    Ann Neurol; 2000 Jul; 48(1):60-4. PubMed ID: 10894216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vigabatrin associated visual field loss: a clinical audit to study prevalence, drug history and effects of drug withdrawal.
    Newman WD; Tocher K; Acheson JF
    Eye (Lond); 2002 Sep; 16(5):567-71. PubMed ID: 12194070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visual field constriction on vigabatrin.
    Prescrire Int; 2000 Feb; 9(45):210-1. PubMed ID: 11503799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Vigabatrin and visual field defects. A Danish material with evaluation of different screening methods].
    Riise P; Fledelius HC; Rogvi-Hansen Bà
    Ugeskr Laeger; 2003 Mar; 165(10):1034-8. PubMed ID: 12645411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visual field constriction in children with epilepsy on vigabatrin treatment.
    Iannetti P; Spalice A; Perla FM; Conicella E; Raucci U; Bizzarri B
    Pediatrics; 2000 Oct; 106(4):838-42. PubMed ID: 11015531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetic resonance imaging abnormalities associated with vigabatrin in patients with epilepsy.
    Wheless JW; Carmant L; Bebin M; Conry JA; Chiron C; Elterman RD; Frost M; Paolicchi JM; Donald Shields W; Thiele EA; Zupanc ML; Collins SD
    Epilepsia; 2009 Feb; 50(2):195-205. PubMed ID: 19054414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binasal visual field defects are not specific to vigabatrin.
    Gonzalez P; Sills GJ; Parks S; Kelly K; Stephen LJ; Keating D; Dutton GN; Brodie MJ
    Epilepsy Behav; 2009 Nov; 16(3):521-6. PubMed ID: 19815465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vigabatrin-associated visual field defects in children.
    Russell-Eggitt IM; Mackey DA; Taylor DS; Timms C; Walker JW
    Eye (Lond); 2000 Jun; 14 ( Pt 3A)():334-9. PubMed ID: 11026995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symptomatic and asymptomatic visual loss in patients taking vigabatrin.
    Daneshvar H; Racette L; Coupland SG; Kertes PJ; Guberman A; Zackon D
    Ophthalmology; 1999 Sep; 106(9):1792-8. PubMed ID: 10485552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vigabatrin retinopathy in an Irish cohort: lack of correlation with dose.
    Kinirons P; Cavalleri GL; O'Rourke D; Doherty CP; Reid I; Logan P; Liggan B; Delanty N
    Epilepsia; 2006 Feb; 47(2):311-7. PubMed ID: 16499754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The function of eye and vision system in children and youth treated with vigabatrin--our own experiences].
    Pojda-Wilczek D; Emich-Widera E; Herba E; Pojda SM; Marszał E
    Klin Oczna; 2005; 107(10-12):654-7. PubMed ID: 16619812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.